ChronoScale 

$17.58
57
-$0.67-3.7% 08:58 Today

Statistics

Day High
17.57
Day Low
17.48
52W High
28.2
52W Low
2.91
Volume
5,531
Avg. Volume
-
Mkt Cap
2.54B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3AugExpected
Q1 2026
Next
-0.06
-0.05
-0.04
-0.03
Expected EPS
-0.0626
Actual EPS
N/A

Financials

-91.37%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
12.8MRevenue
-11.7MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CHRN. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Resmed
RMD
Mkt Cap30.41B
ResMed Inc. competes in the development, manufacturing, and marketing of medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders, including sleep apnea, a field closely related to Ekso Bionics' focus on medical devices for physical assistance.
Community Health Systems
CYH
Mkt Cap518.57M
Community Health Systems, Inc. operates hospitals and healthcare facilities, which could be potential users of Ekso Bionics' medical devices, making them indirect competitors in the healthcare solutions market.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet Holdings, Inc. manufactures and markets orthopedic reconstructive products, competing with Ekso Bionics in the broader market for medical devices that aid mobility.
Smith & Nephew
SNN
Mkt Cap12.78B
Smith & Nephew plc designs, manufactures, and markets medical devices for the orthopedic market, competing with Ekso Bionics in the development of technologies for physical rehabilitation.
Medtronic
MDT
Mkt Cap106.49B
Medtronic plc specializes in medical technologies, services, and solutions, including those for spinal and musculoskeletal conditions, making it a competitor in the medical device market alongside Ekso Bionics.
Stryker
SYK
Mkt Cap125.18B
Stryker Corporation specializes in medical technologies, including orthopedics, making it a competitor in the market for devices that support physical mobility and rehabilitation.
Globus Medical
GMED
Mkt Cap10.88B
Globus Medical, Inc. focuses on musculoskeletal solutions, directly competing with Ekso Bionics in the development and marketing of medical devices aimed at improving physical mobility.
Boston Scientific
BSX
Mkt Cap67.09B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing indirectly with Ekson Bionics by offering alternative solutions for patient care.

About

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.
Show more...
CEO
Ms. Ying Cenly Chen
Employees
55
Country
United States
ISIN
US1709241046

Listings

0 Comments

Share your thoughts

FAQ

What is ChronoScale stock price today?
The current price of CHRN is $17.58 USD — it has decreased by -3.7% in the past 24 hours. Watch ChronoScale stock price performance more closely on the chart.
What is ChronoScale stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange ChronoScale stocks are traded under the ticker CHRN.
What is ChronoScale market cap?
Today ChronoScale has the market capitalization of 2.54B
When is the next ChronoScale earnings date?
ChronoScale is going to release the next earnings report on August 03, 2026.
What is ChronoScale revenue for the last year?
ChronoScale revenue for the last year amounts to 12.8M USD.
What is ChronoScale net income for the last year?
CHRN net income for the last year is -11.7M USD.
How many employees does ChronoScale have?
As of July 08, 2026, the company has 55 employees.
In which sector is ChronoScale located?
ChronoScale operates in the Other sector.
When did ChronoScale complete a stock split?
The last stock split for ChronoScale was on June 02, 2025 with a ratio of 1:15.
Where is ChronoScale headquartered?
ChronoScale is headquartered in Dallas, United States.